The value of gonadotropin-releasing hormone-agonists together with other drugs for medical treatment and prevention

Adolf E. Schindler, Schindler AE
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2009 · doi:10.3109/09513590903080928 · PMID:19905992
other OA: bronze public-domain-us
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

This paper reviews the use of gonadotropin-releasing hormone-agonists in conjunction with other medications for medical treatment and prevention purposes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Drug Therapy, Combination Endometriosis Endometriosis Estrogen Receptor Modulators Estrogen Receptor Modulators Female Gonadotropin-Releasing Hormone Humans Leiomyoma Leiomyoma Norpregnenes Norpregnenes Uterine Neoplasms Uterine Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-23T09:30:01.253652+00:00
pubmed
last seen: 2026-05-13T22:13:53.633898+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine